Free Trial
OTCMKTS:SHTDY

Sinopharm Group (SHTDY) Stock Price, News & Analysis

Sinopharm Group logo
$11.76 +0.14 (+1.16%)
As of 05/2/2025 03:47 PM Eastern

About Sinopharm Group Stock (OTCMKTS:SHTDY)

Key Stats

Today's Range
$11.15
$11.96
50-Day Range
$10.84
$12.95
52-Week Range
$10.13
$16.31
Volume
11,512 shs
Average Volume
18,488 shs
Market Capitalization
N/A
P/E Ratio
2.36
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.

Receive SHTDY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sinopharm Group and its competitors with MarketBeat's FREE daily newsletter.

SHTDY Stock News Headlines

Think NVDA’s run was epic? You ain’t seen nothin’ yet
Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?
3 Compelling Dividend Stocks Offering Yields Up To 5.1%
See More Headlines

SHTDY Stock Analysis - Frequently Asked Questions

Sinopharm Group's stock was trading at $13.57 at the start of the year. Since then, SHTDY shares have decreased by 13.4% and is now trading at $11.7550.
View the best growth stocks for 2025 here
.

Shares of SHTDY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Medical Distribution
Sub-Industry
Personal Services
Current Symbol
OTCMKTS:SHTDY
Fax
N/A
Employees
115,959
Year Founded
N/A

Profitability

Trailing P/E Ratio
2.36
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (OTCMKTS:SHTDY) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners